These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7859866)

  • 1. Decline in anti-HAV prevalence in the Milan area between 1958 and 1992.
    Zanetti AR; Romanò L; Tanzi E; Andreassi A; Pozzi A; Panuccio A; Stroffolini T
    Eur J Epidemiol; 1994 Oct; 10(5):633-5. PubMed ID: 7859866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of anti-HAV antibodies (hepatitis A virus) in 18-year-old males from the Florence area].
    Calabri GB; Santini MG; Genovese F; Bambi F; Salvi G; Calabri G
    Pediatr Med Chir; 1999; 21(5 Suppl):219-20. PubMed ID: 10963011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific prevalence of hepatitis A antibody in Thai children.
    Kalayanarooj S; Vaughn DW; Snitbhan R; Ariyasriwatana C
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):709-11. PubMed ID: 9139381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study.
    García-Fulgueiras A; Rodriguez T; Tormo MJ; Perez-Flores D; Chirlaque D; Navarro C
    Eur J Epidemiol; 1997 Jun; 13(4):481-3. PubMed ID: 9258557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum antibodies against hepatitis A virus among subjects of middle and low socioeconomic levels in urban area of Santiago, Chile].
    Lagos R; Potin M; Muñoz A; Abrego P; San Martín OS; Ureta AM; Bustamante C
    Rev Med Chil; 1999 Apr; 127(4):429-36. PubMed ID: 10451608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The seroepidemiology of the hepatitis A virus in children and adolescents].
    Lasheras Lozano ML; Gil Miguel A; Santos Santos M; Rey Calero J
    Aten Primaria; 1994 Jan; 13(1):36-8. PubMed ID: 8136445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in incidence of hepatitis A infection in Milan. A serologic study.
    Zanetti AR; Ferroni P; Bastia A
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):816-20. PubMed ID: 233296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
    Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
    Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil].
    Clemens SA; da Fonseca JC; Azevedo T; Cavalcanti A; Silveira TR; Castilho MC; Clemens R
    Rev Soc Bras Med Trop; 2000; 33(1):1-10. PubMed ID: 10881112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel.
    Karetnyi YV; Mendelson E; Shlyakhov E; Rubinstein E; Golubev N; Levin R; Sandler M; Schreiber M; Rubinstein U; Shif I
    J Med Virol; 1995 May; 46(1):61-5. PubMed ID: 7623008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seroepidemiology of hepatitis A and B in a Japanese town.
    Akbar SM; Onji M; Kanaoka M; Horiike N; Michitaka K; Masumoto T; Nonaka T; Kanda K; Kajino K; Kumamoto I
    Asia Pac J Public Health; 1992-1993; 6(2):26-9. PubMed ID: 1339221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of antibodies against hepatitis A virus (HAV) in a population of Mexican children].
    Ramirez Mayans JA; Cervantes Bustamante R; Jiron Castro R; Oyervides Garcia CI; Mata Rivera N; Navarrete Delgadillo Natividad MA; Sosa Martinez MC
    Acta Gastroenterol Latinoam; 1997; 27(2):99-102. PubMed ID: 9412137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil.
    Queiróz DA; Cardoso DD; Martelli CM; Martins RM; Porto SO; Borges AM; Azevedo MS; Daher RR
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):427-33. PubMed ID: 8729753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody titers against the hepatitis A virus in a healthy population from an urban health area].
    Jiménez Rodríguez-Vila M; Hernández Gajate M; Pascual Martín ML; Martín Rojo M; Fernández Alonso MC; Gómez Arranz A; Hernández Pérez P; Martín Rodríguez JF; Orduña Domingo A; Caro-Patón Gómez A
    Aten Primaria; 1992 Jan; 9(1):10-2. PubMed ID: 1339210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of hepatitis A antibodies in epidemiological practice].
    Kornachev AS; Mikhaĭlova NB; Dubrovskaia LR; Sitkov VI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):59-60. PubMed ID: 2166986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions.
    Zuin M; Caserta C; Romanò L; Mele A; Zanetti A; Cannatelli R; Giorgini A; Tagliacarne C; Amante A; Marcucci F; Battezzati PM
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):479-485. PubMed ID: 27785638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high degree of exposure to hepatitis A virus infection in urban children in Cameroon.
    Stroffolini T; Chiaramonte M; Ngatchu T; Rapicetta M; Sarrecchia B; Chionne P; Lantum D; Naccarato R
    Microbiologica; 1991 Jul; 14(3):199-203. PubMed ID: 1656166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period.
    Furusyo N; Hayashi J; Sawayama Y; Kawakami Y; Kishihara Y; Kashiwagi S
    Am J Trop Med Hyg; 1998 Nov; 59(5):693-8. PubMed ID: 9840583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.
    Vranckx R; Muylle L
    Infection; 1990; 18(6):364-6. PubMed ID: 1963883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of anti-HAV antibodies and efficacy of pre-vaccine detection at institutions for mentally retarded of the city of Alicante].
    Martínez-Campillo F; Terán M; Alvarez M; Rigo MV; Roda J; Salinas M; García JM
    Aten Primaria; 2000 May; 25(8):552-5. PubMed ID: 10876948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.